BioSpace News Archive

Able Medical Devices announces the recent launch of its Valkyrie™ Thoracic Fixation System, the market’s first single-use radiolucent plating system designed to span the osteotomy and close the sternum after open heart surgery.

Oncology Pharma Inc. is releasing a White Paper outlining 5 innovative ways to improve patient engagement in clinical trials.

Vertex Announces U.S. FDA Approval for TRIKAFTA ® in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations.

Halberd Corporation (OTC PINK:HALB) commences experimentations to eradicate three of the principal components of Alzheimer’s Disease.

Syros Pharmaceuticals today announced that its Chief Executive Officer, Nancy Simonian, M.D., will participate in a fireside chat at the JMP Securities 2021 Life Sciences Conference.

Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it is initiating immediate availability of Triamcinolone Hexacetonide Injectable Suspension, USP (20 mg/ml) (TH) in the United States via the U.S. Food and Drug Administration’s (FDA) CDER Drug Shortage program

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, today announced that the U.S. Food and Drug Administration (FDA) granted BREXAFEMME (ibrexafungerp tablets), five years of exclusivity extension under the Generating Antibiotic Incentives Now (GAIN) Act.

Health Logic Interactive Inc. (“Health Logic” or the “Company”) (TSXV: CHIP.H) (OTCPK: CHYPF) is pleased to announce the addition of new members to its Scientific Advisory Board (“SAB”) including nephrology specialists Dr. Adeera Levin from the University of British Columbia, Dr. Lesley Inker of Tufts Medical Center, and Dr. Susan Quaggin of Northwestern University.

Integrated solution incorporates testing protocols and real-time test results to help ensure safer, healthier campuses, healthcare facilities and other venues.

BGG World (BGG) is extremely pleased to announce a new positive clinical trial publication related to MyrtiPro® for eye health